Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585494 · ClinicalTrials.gov registry record
Prevalence of Inpatient Hyperglycemia: Risks, Complications and Outcomes
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 302
- Enrollment target
NCT00585494: Completed study, sponsored by University of Wisconsin, Madison.
NCT00585494 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 302 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00585494 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 302 participants
- Enrollment target
Study Summary
This protocol will determine the prevalence of hyperglycemia and diabetes in the elective orthopedic population at the University of Wisconsin. It will also determine if there is a difference in outcomes. The study hypothesizes that at least 10% of patients will have some degree of impaired glucose regulation that has previously been undiagnosed.
Primary Outcome
Number of orthopedic patients that have elevated fasting blood glucose levels preoperatively
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-08 |
What the finished NCT00585494 record still lists
NCT00585494 is an observational study that tracks outcomes without assigning an intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00585494 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00585494 about?
NCT00585494 is a clinical study titled "Prevalence of Inpatient Hyperglycemia: Risks, Complications and Outcomes". This protocol will determine the prevalence of hyperglycemia and diabetes in the elective orthopedic population at the University of Wisconsin. It will also determine if there is a difference in outcomes. The study hypothesizes that at least 10% of patients will have some degree of impaired glucose ...
What is the current status of trial NCT00585494?
This trial is currently completed. The enrollment target is 302 participants. The study started on 2007-12. Estimated completion is 2010-08.
Who is sponsoring clinical trial NCT00585494?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia